[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported multiple transactions on Form 4. On 03/07/2025 he disposed of 5,700 Class A shares as a gift to a donor-advised fund, leaving 291,439 shares beneficially owned. On 09/24/2025 he exercised 2,100 stock options with an exercise price of $5.01 under a Rule 10b5-1 trading plan adopted 03/04/2025, and concurrently sold 2,100 shares at $56.52. The Form 4 shows 2,100 underlying shares from the options and indicates total Class A beneficial ownership figures of 174,042 shares for options and 291,439–293,539 shares across reported lines. The filing discloses that the options vest over a four-year service schedule that began in 03/2022.

Positive

• Transactions fully disclosed on Form 4 with transaction codes, quantities, prices, and explanations
• Use of a Rule 10b5-1 trading plan adopted 03/04/2025 provides pre-arranged, documented execution of option exercise and sale
• Charitable gift of 5,700 shares to a donor-advised fund is explicitly reported

Negative

• Insider sale of 2,100 shares on 09/24/2025 at $56.52 could be viewed negatively by some investors due to insider liquidation
• Reduction in direct ownership following the gift and sale transactions is reported, lowering immediate beneficial holdings

Insights

Securities Analyst

TL;DR Insider executed a Rule 10b5-1 plan to exercise options and sell shares while also gifting shares to a donor-advised fund.

The reporting shows routine insider activity rather than an unexplained one-off. The 03/07/2025 entry documents a charitable gift of 5,700 Class A shares reducing direct holdings to 291,439 shares. The 09/24/2025 transactions were effected under a documented Rule 10b5-1 plan adopted 03/04/2025, with exercise at $5.01 and sale at $56.52 of 2,100 shares, reflecting option monetization under an established trading plan. The filing also clarifies the service-based vesting schedule for the options that began in March 2022 and vests monthly over four years.

Corporate Governance Specialist

TL;DR Disclosure is complete and follows standard protocols: gift, documented 10b5-1 plan, and vesting terms disclosed.

The Form 4 includes required details: transaction codes, quantities, prices, the existence and adoption date of a 10b5-1 plan, and an explanation that 5,700 shares were gifted to a donor-advised fund. Vesting terms for the options are specified as service-based with inception in March 2022. Signatures and filing dates are present, indicating procedural compliance with Section 16 reporting obligations. No additional material disclosures such as unusual option repricing or related-party transactions are reported in the document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/07/2025		G(1)		5,700	D	$0	291,439	D
Class A Common Stock	09/24/2025		M(2)		2,100	A	$5.01	293,539	D
Class A Common Stock	09/24/2025		S(2)		2,100	D	$56.52	291,439	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	09/24/2025		M(2)			2,100	(3)	02/24/2032	Class A Common Stock	2,100	$0	174,042	D

Explanation of Responses:

1. These shares represent a gift to a Donor Advised Fund.

2. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Michael Chi report for HIMS?

He reported a gift of 5,700 Class A shares on 03/07/2025 and exercise and sale of 2,100 option-shares on 09/24/2025 under a 10b5-1 plan.

Were the 09/24/2025 trades by Michael Chi part of a pre-arranged plan?

Yes. The Form 4 states the option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on 03/04/2025.

What were the prices for the exercised options and the subsequent sale?

The exercise price was $5.01 per option and the sale price reported was $56.52 per share on 09/24/2025.

How many Class A shares does Michael Chi beneficially own after these transactions?

The filing reports beneficial ownership lines showing 291,439 shares and an entry reflecting 293,539 after the exercise prior to the reported sale; the Form 4 lists option-derived beneficial ownership of 174,042 shares.

What is the vesting schedule for the reported options?

The options vest over a four-year period with 1/48th vesting on March 24, 2022 and 1/48th vesting monthly thereafter.